logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
NUVL
Nuvalent, Inc.
123.60
2 x 88.94
2 x 158.15
bid
ask
+
0.10
0.08%
2 @ 06:06 AM
124.00 +0.40 (0.32%)
Ytd22.88%
1y58.44%
123.50
day range
123.63
71.13
52 week range
123.69
Open123.56Prev Close123.50Low123.50High123.63Mkt Cap9.78B
Vol1.30MAvg Vol2.14MEPS-6.06P/EN/AForward P/E-29.91
Beta1.15Short Ratio0.73Inst. Own113.09%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg108.59200-d Avg101.421yr Est125.13

NUVL News

Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders
globenewswire.com
Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Publi

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSE - TMHC),
globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, I

BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi

Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?
gurufocus.com
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?

Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 202

Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi

This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
benzinga.com
This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See
benzinga.com
Bernstein Downgrades Nuvalent to Market Perform, Lowers Price Target to $124

Bernstein analyst Jeffrey Walch downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Market Perfo

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
benzinga.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Y

During market turbulence, investors turn to dividend-yielding stocks. Benzinga offers latest analyst

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
benzinga.com
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top analysts changed outlook on top names, including downgrades, upgrades, and initiations. Check ou
benzinga.com
Barclays Downgrades Nuvalent to Equal-Weight, Lowers Price Target to $124

Barclays analyst Etzer Darout downgrades Nuvalent (NASDAQ:NUVL) from Overweight to Equal-Weight a
benzinga.com
Wedbush Downgrades Nuvalent to Neutral, Lowers Price Target to $124

Wedbush analyst David Nierengarten downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Neutral a
benzinga.com
UBS Downgrades Nuvalent to Neutral, Lowers Price Target to $124

UBS analyst David Dai downgrades Nuvalent (NASDAQ:NUVL) from Buy to Neutral and lowers the price

benzinga.com
Guggenheim Downgrades Nuvalent to Neutral, Lowers Price Target to $124

Guggenheim analyst Brad Canino downgrades Nuvalent (NASDAQ:NUVL) from Buy to Neutral and lowers t

Super Micro Computer, Draftkings, Cracker Barrel, Nuvalent And Oracle: Why These 5 Stocks Are On Investors' Radars Today
benzinga.com
Super Micro Computer, Draftkings, Cracker Barrel, Nuvalent And Oracle: Why These 5 Stocks Are On Inv

Major U.S. indexes finished Tuesday mixed, with the Dow Jones Industrial Average gaining 0.17% to 50

Nasdaq 100 Tumbles Over 3%, Marvell Crashes 12%: Stock Market Today
benzinga.com
Nasdaq 100 Tumbles Over 3%, Marvell Crashes 12%: Stock Market Today

The Nasdaq 100 sank 3.3% Tuesday as AI and optical stocks cratered, while cash rotated into real est

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Crude Oil Falls Over 5%; US Trade Gap Narrows In April
benzinga.com
Crude Oil Falls Over 5%; US Trade Gap Narrows In April

US stocks down, Dow Jones drops 300 points. Real estate shares up, technology stocks down. U.S. trad
benzinga.com
Wells Fargo Downgrades Nuvalent to Equal-Weight, Raises Price Target to $124

Wells Fargo analyst Eva Fortea Verdejo downgrades Nuvalent (NASDAQ:NUVL) from Overweight to Equal
benzinga.com
LifeSci Capital Downgrades Nuvalent to Market Perform, Announces $124 Price Target

LifeSci Capital downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Market Perform and announces

benzinga.com
HC Wainwright & Co. Downgrades Nuvalent to Neutral, Announces $124 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Nuvalent (NASDAQ:NUVL) from Buy

JM Smucker, Nuvalent, FuelCell Energy And Other Big Stocks Moving Higher On Tuesday
benzinga.com
JM Smucker, Nuvalent, FuelCell Energy And Other Big Stocks Moving Higher On Tuesday

US stocks higher, Dow Jones index up 300 points on strong earnings and sales guidance from J.M. Smuc

This Ingredion Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
benzinga.com
This Ingredion Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Anal
benzinga.com
Wedbush Downgrades Nuvalent to Neutral, Lowers Price Target to $124

Wedbush analyst David Nierengarten downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Neutral a

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent
benzinga.com
GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuva

GSK will acquire Nuvalent for $10.6 billion to expand its lung cancer pipeline as Nuvalent shares su

Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
benzinga.com
GSK Enters Agreement To Acquire Nuvalent For $10.6B At $124 Per Share, A 40% Premium To Last Closing

Multi-product oncology deal for assets that have validated targets and aim to address efficacy and/o